New drug calms kids after cleft palate surgery
NCT ID NCT04928391
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a single dose of dexmedetomidine, given during surgery, can prevent severe agitation in children aged 1-7 after cleft palate repair. Sixty children were randomly assigned to receive either the drug or a placebo (saline). The main goal was to measure emergence delirium using a standard scoring system. The results could help improve recovery comfort for young patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEFT PALATE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut university hospital
Asyut, Egypt
-
Omar Soliman
Asyut, Assuit, Assuit universi, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a blood-derived patch strengthen cleft palate repair?
- Baby teeth stem cells may spare kids a second surgery for cleft palate repair
- Nerve block may ease pain and cut opioid use in kids after palate surgery
- Can we predict breathing problems in cleft surgery? new study aims to find out
- MRI scans reveal hidden causes of speech issues in cleft palate kids
- Pain-blocking shot for kids' cleft palate surgery never tested